SLC5A2 and retinal disorder: Future research can use the information from this study to predict whether SGLT-2 inhibitors can lead to sufficient improvement in long term outcomes—for example, from reduced incidence and costs of complications such as retinopathy, amputation, or end stage kidney disease, to justify any additional costs.